Skip to content
Screener

Chemed CHE Excise Tax On Share Repurchase

Excise Tax On Share Repurchase at other companies

BK
BKBK
$6M-7.7%
Pultegroup logo
PultegroupPHM
$2.89M+19.2%
CRA International logo
CRA InternationalCRAI
$270K-36.8%
CRA International logo
CRA InternationalCRAI
$270K-36.8%
United Therapeutics logo
United TherapeuticsUTHR
$8.4M
United Therapeutics logo
United TherapeuticsUTHR
$8.4M

Other financials

Income statement

See full
Revenue$673.3M+8.8%
Gross profit$221.5M+19.9%
Operating income$89.2M+31.0%
Net income$67.7M+29.0%
EPS (diluted)$5.13+43.7%

Balance sheet

See full
Cash & equivalents$40.2M-83.9%
Total debt$181.3M+24.5%
Total equity$830.5M-30.7%
Total assets$1.6B-8.0%

Cash flow

See full
Operating cash flow$84.8M-38.8%
CapEx$15.5M-1.8%
Free cash flow$69.3M-43.6%

Valuation

See full
Market cap$7.18B+14.9%
Enterprise value$7.32B+19.1%
P/E26.1×+4.6×
P/S2.8×+0.3×

Profitability

See full
Gross margin33.1%-0.5pp
Operating margin13.5%-1.2pp
Net margin10.6%-1.0pp
FCF margin12.5%-2.3pp

Returns & leverage

See full
Return on equity27.1%+3.0pp
Debt / equity0.2×+0.1×
Current ratio0.9×-1.0×

Where this comes from

Reported directly by Chemed in its filing.

Tagged under the XBRL concept che:ExciseTaxOnShareRepurchase.

The source filing: Chemed’s 10-Q, filed April 28, 2026.

Filed
Apr 28, 2026, 9:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000019584-26-000012
For the three months ended March 31, 2026 and 2025:For the three months ended March 31, 2026 and 2025: / Capital / StockFor the three months ended March 31, 2026 and 2025: / Paid-in / CapitalFor the three months ended March 31, 2026 and 2025: / Retained / EarningsTreasury / Stock- / at CostDeferred / Compensation / Payable in / Company / StockTotal
Dividends paid ($0.60 per share)--(8,173)--(8,173)
Stock awards and exercise of stock options1211,935-(1,482)-10,465
Purchases of treasury stock---(197,682)-(197,682)
Excise tax on share repurchase---(1,920)-(1,920)
Other-(402)-(44)43(403)
Balance at March 31, 2026$$37,607$1,603,730$3,013,504$(3,809,245)$2,398847,994
Deferred
Compensation

Item 1. Financial Statements

FAQ

What is Chemed's excise tax on share repurchase?
Chemed (CHE) reported excise tax on share repurchase of -$1.92M in Q1 2026.
What does excise tax on share repurchase mean?
The specific tax expense incurred by the corporation on the value of shares repurchased during the reporting period. This reflects the regulatory cost associated with share buyback programs under current tax legislation. It is an important consideration for evaluating the true net cost of returning capital to shareholders.

Ask your AI about Chemed's excise tax on share repurchase.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude